A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients
Conditions: Head and Neck Neoplasm; Chemoradiotherapy Intervention: Drug: SZKJT(San-Zhong-Kui-Jian-Tang) Sponsor: China Medical University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2022 Category: Research Source Type: clinical trials